MAP9 Exhibits Protumor Activities and Immune Escape toward Bladder Cancer by Mediating TGF-β1 Pathway

Figure 1

MAP9, the strongest proliferation inhibition target, screened by qRT-PCR and HCS. (a) Clustering of differentially expressed gene sets [2]. (b) qRT-PCR to identify the expression levels of 33 few reported genes selected from 809 downregulated genes. (c) Cell number count of HCS proliferation detection. (d) Proliferation fold of HCS proliferation detection.

(a)

(b)

(c)

(d)